Immune checkpoint and angiogenic inhibitors for the treatment of hepatocellular carcinoma: It takes two to tangle Caecilia Sukowati; Loraine Kay D. Cabral; Claudio Tiribelli;

Progress of targeted and immunotherapy for hepatocellular carcinoma and the application of next-generation sequencing Fan Yang; Kaige Deng; Haoran Zheng; Zhenting Liu; Yongchang Zheng;

The ITA.LI.CA Consortium: How multicentre collaboration helped shape the management of patients with hepatocellular carcinoma on the basis of real-world evidence Franco Trevisani; Edoardo G. Giannini;